血漿分画製品の世界市場2022年

【英語タイトル】Global Plasma Fractionation Product Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

GlobalInfoResearchが出版した調査資料(GIR-22F19549)・商品コード:GIR-22F19549
・発行会社(調査会社):GlobalInfoResearch
・発行日:2022年11月
・ページ数:101
・レポート言語:英文
・レポート形式:PDF
・納品方法:Eメール(2~3営業日)
・調査対象地域:グローバル、北米、ヨーロッパ、アジア太平洋、南アメリカ、中東・アフリカ、主要国
・産業分野:医薬品
◆販売価格オプション(消費税別)
Single UserUSD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi UserUSD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate UserUSD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

「Global Plasma Fractionation Product Market 2022」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
グローバルインフォリサーチ社の最新の調査によると、世界の血漿分画製品の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx%の成長率で成長すると予想されます。

血漿分画製品市場はタイプ(種類)とアプリケーション(用途)によって区分されます。2017年~2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメントは次をカバーします。
・凝固因子、免疫グロブリン、アルブミン、その他

アプリケーション別セグメントは次のように区分されます。
・免疫学、血液学、その他

世界の血漿分画製品市場の主要な市場プレーヤーは以下のとおりです。
・Takeda、CSL、Grifols、Octapharma、Kedrion、LFB Group、Biotest、BPL、RAAS、CBPO、Hualan Bio

地域別セグメントは次の地域・国をカバーします。
・北米市場(米国、カナダ、メキシコ)
・ヨーロッパ市場(ドイツ、フランス、イギリス、ロシア、イタリア)
・アジア太平洋市場(日本、中国、韓国、インド、東南アジア、オーストラリア)
・南米市場(ブラジル、アルゼンチン、コロンビア)
・中東・アフリカ市場(サウジアラビア、UAE、エジプト、南アフリカ)

本調査レポートの内容は計15章あります。
・第1章では、血漿分画製品製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な血漿分画製品メーカーの企業概要、2019年~2022年までの血漿分画製品の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な血漿分画製品メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年~2028年までの地域別血漿分画製品の販売量、売上、成長性を示しています。
・第5、6章では、2017年~2028年までの血漿分画製品のタイプ別とアプリケーション別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年~2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年~2028年までの主要地域での血漿分画製品市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および血漿分画製品の産業チェーンを掲載しています。
・第13、14、15章では、血漿分画製品の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 血漿分画製品の概要
- タイプ別分析(2017年vs2021年vs2028年):凝固因子、免疫グロブリン、アルブミン、その他
- アプリケーション別分析(2017年vs2021年vs2028年):免疫学、血液学、その他
- 世界の血漿分画製品市場規模・予測
- 世界の血漿分画製品生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報(企業概要、製品概要、販売量、価格、売上)
- Takeda、CSL、Grifols、Octapharma、Kedrion、LFB Group、Biotest、BPL、RAAS、CBPO、Hualan Bio
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・タイプ別分析2017年-2028年:凝固因子、免疫グロブリン、アルブミン、その他
・アプリケーション別分析2017年-2028年:免疫学、血液学、その他
・血漿分画製品の北米市場分析
- 血漿分画製品の北米市場:タイプ別市場規模2017年-2028年
- 血漿分画製品の北米市場:アプリケーション別市場規模2017年-2028年
- 主要国別市場規模:アメリカ、カナダ、メキシコなど
・血漿分画製品のヨーロッパ市場分析
- :血漿分画製品のヨーロッパ市場:タイプ別市場規模2017年-2028年
- :血漿分画製品のヨーロッパ市場:アプリケーション別市場規模2017年-2028年
- 主要国別市場規模:ドイツ、イギリス、フランス、ロシア、イタリアなど
・血漿分画製品のアジア太平洋市場分析
- 血漿分画製品のアジア太平洋市場:タイプ別市場規模2017年-2028年
- 血漿分画製品のアジア太平洋市場:アプリケーション別市場規模2017年-2028年
- 主要国別市場規模:中国、日本、韓国、インド、東南アジア、オーストラリアなど
・血漿分画製品の南米市場分析
- 血漿分画製品の南米市場:タイプ別市場規模2017年-2028年
- 血漿分画製品の南米市場:アプリケーション別市場規模2017年-2028年
- 主要国別市場規模:ブラジル、アルゼンチンなど
・血漿分画製品の中東・アフリカ市場分析
- 血漿分画製品の中東・アフリカ市場:タイプ別市場規模2017年-2028年
- 血漿分画製品の中東・アフリカ市場:アプリケーション別市場規模2017年-2028年
- 主要国別市場規模:サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Plasma Fractionation Product market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Plasma Fractionation Product market size is estimated to be worth US$ 28910 million in 2021 and is forecast to a readjusted size of USD 46820 million by 2028 with a CAGR of 7.1% during review period. Immunology accounting for % of the Plasma Fractionation Product global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Coagulation Factor segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Plasma Fractionation Product include Takeda, CSL, Grifols, Octapharma, and Kedrion, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Plasma Fractionation Product market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Coagulation Factor
Immune Globulin
Albumin
Other
Market segment by Application can be divided into
Immunology
Hematology
Other
The key market players for global Plasma Fractionation Product market are listed below:
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Plasma Fractionation Product product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Plasma Fractionation Product, with price, sales, revenue and global market share of Plasma Fractionation Product from 2019 to 2022.
Chapter 3, the Plasma Fractionation Product competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Plasma Fractionation Product breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Plasma Fractionation Product market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Plasma Fractionation Product.
Chapter 13, 14, and 15, to describe Plasma Fractionation Product sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Plasma Fractionation Product Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Plasma Fractionation Product Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Coagulation Factor
1.2.3 Immune Globulin
1.2.4 Albumin
1.2.5 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Plasma Fractionation Product Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Immunology
1.3.3 Hematology
1.3.4 Other
1.4 Global Plasma Fractionation Product Market Size & Forecast
1.4.1 Global Plasma Fractionation Product Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Plasma Fractionation Product Sales in Volume (2017-2028)
1.4.3 Global Plasma Fractionation Product Price (2017-2028)
1.5 Global Plasma Fractionation Product Production Capacity Analysis
1.5.1 Global Plasma Fractionation Product Total Production Capacity (2017-2028)
1.5.2 Global Plasma Fractionation Product Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Plasma Fractionation Product Market Drivers
1.6.2 Plasma Fractionation Product Market Restraints
1.6.3 Plasma Fractionation Product Trends Analysis
2 Manufacturers Profiles
2.1 Takeda
2.1.1 Takeda Details
2.1.2 Takeda Major Business
2.1.3 Takeda Plasma Fractionation Product Product and Services
2.1.4 Takeda Plasma Fractionation Product Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 CSL
2.2.1 CSL Details
2.2.2 CSL Major Business
2.2.3 CSL Plasma Fractionation Product Product and Services
2.2.4 CSL Plasma Fractionation Product Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Grifols
2.3.1 Grifols Details
2.3.2 Grifols Major Business
2.3.3 Grifols Plasma Fractionation Product Product and Services
2.3.4 Grifols Plasma Fractionation Product Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Octapharma
2.4.1 Octapharma Details
2.4.2 Octapharma Major Business
2.4.3 Octapharma Plasma Fractionation Product Product and Services
2.4.4 Octapharma Plasma Fractionation Product Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Kedrion
2.5.1 Kedrion Details
2.5.2 Kedrion Major Business
2.5.3 Kedrion Plasma Fractionation Product Product and Services
2.5.4 Kedrion Plasma Fractionation Product Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 LFB Group
2.6.1 LFB Group Details
2.6.2 LFB Group Major Business
2.6.3 LFB Group Plasma Fractionation Product Product and Services
2.6.4 LFB Group Plasma Fractionation Product Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Biotest
2.7.1 Biotest Details
2.7.2 Biotest Major Business
2.7.3 Biotest Plasma Fractionation Product Product and Services
2.7.4 Biotest Plasma Fractionation Product Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 BPL
2.8.1 BPL Details
2.8.2 BPL Major Business
2.8.3 BPL Plasma Fractionation Product Product and Services
2.8.4 BPL Plasma Fractionation Product Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 RAAS
2.9.1 RAAS Details
2.9.2 RAAS Major Business
2.9.3 RAAS Plasma Fractionation Product Product and Services
2.9.4 RAAS Plasma Fractionation Product Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 CBPO
2.10.1 CBPO Details
2.10.2 CBPO Major Business
2.10.3 CBPO Plasma Fractionation Product Product and Services
2.10.4 CBPO Plasma Fractionation Product Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Hualan Bio
2.11.1 Hualan Bio Details
2.11.2 Hualan Bio Major Business
2.11.3 Hualan Bio Plasma Fractionation Product Product and Services
2.11.4 Hualan Bio Plasma Fractionation Product Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Plasma Fractionation Product Breakdown Data by Manufacturer
3.1 Global Plasma Fractionation Product Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Plasma Fractionation Product Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Plasma Fractionation Product
3.4 Market Concentration Rate
3.4.1 Top 3 Plasma Fractionation Product Manufacturer Market Share in 2021
3.4.2 Top 6 Plasma Fractionation Product Manufacturer Market Share in 2021
3.5 Global Plasma Fractionation Product Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Plasma Fractionation Product Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Plasma Fractionation Product Market Size by Region
4.1.1 Global Plasma Fractionation Product Sales in Volume by Region (2017-2028)
4.1.2 Global Plasma Fractionation Product Revenue by Region (2017-2028)
4.2 North America Plasma Fractionation Product Revenue (2017-2028)
4.3 Europe Plasma Fractionation Product Revenue (2017-2028)
4.4 Asia-Pacific Plasma Fractionation Product Revenue (2017-2028)
4.5 South America Plasma Fractionation Product Revenue (2017-2028)
4.6 Middle East and Africa Plasma Fractionation Product Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Plasma Fractionation Product Sales in Volume by Type (2017-2028)
5.2 Global Plasma Fractionation Product Revenue by Type (2017-2028)
5.3 Global Plasma Fractionation Product Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Plasma Fractionation Product Sales in Volume by Application (2017-2028)
6.2 Global Plasma Fractionation Product Revenue by Application (2017-2028)
6.3 Global Plasma Fractionation Product Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Plasma Fractionation Product Sales by Type (2017-2028)
7.2 North America Plasma Fractionation Product Sales by Application (2017-2028)
7.3 North America Plasma Fractionation Product Market Size by Country
7.3.1 North America Plasma Fractionation Product Sales in Volume by Country (2017-2028)
7.3.2 North America Plasma Fractionation Product Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Plasma Fractionation Product Sales by Type (2017-2028)
8.2 Europe Plasma Fractionation Product Sales by Application (2017-2028)
8.3 Europe Plasma Fractionation Product Market Size by Country
8.3.1 Europe Plasma Fractionation Product Sales in Volume by Country (2017-2028)
8.3.2 Europe Plasma Fractionation Product Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Plasma Fractionation Product Sales by Type (2017-2028)
9.2 Asia-Pacific Plasma Fractionation Product Sales by Application (2017-2028)
9.3 Asia-Pacific Plasma Fractionation Product Market Size by Region
9.3.1 Asia-Pacific Plasma Fractionation Product Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Plasma Fractionation Product Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Plasma Fractionation Product Sales by Type (2017-2028)
10.2 South America Plasma Fractionation Product Sales by Application (2017-2028)
10.3 South America Plasma Fractionation Product Market Size by Country
10.3.1 South America Plasma Fractionation Product Sales in Volume by Country (2017-2028)
10.3.2 South America Plasma Fractionation Product Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Plasma Fractionation Product Sales by Type (2017-2028)
11.2 Middle East & Africa Plasma Fractionation Product Sales by Application (2017-2028)
11.3 Middle East & Africa Plasma Fractionation Product Market Size by Country
11.3.1 Middle East & Africa Plasma Fractionation Product Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Plasma Fractionation Product Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Plasma Fractionation Product and Key Manufacturers
12.2 Manufacturing Costs Percentage of Plasma Fractionation Product
12.3 Plasma Fractionation Product Production Process
12.4 Plasma Fractionation Product Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Plasma Fractionation Product Typical Distributors
13.3 Plasma Fractionation Product Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer



★調査レポート[血漿分画製品の世界市場2022年] (コード:GIR-22F19549)販売に関する免責事項を必ずご確認ください。
★調査レポート[血漿分画製品の世界市場2022年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆